Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study

Journal of Rheumatology

Volumn 35, Issue 12, 2008, Pages 2439-2444

  Arkachaisri, Thaschawee ^a   Fertig, Noreen ^b   Pino, Sally ^a,b   Medsger Jr , Thomas A ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Clinicalassociations; Linear scleroderma

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CALCIPOTRIOL; CHROMATIN ANTIBODY; CORTICOSTEROID; HISTONE ANTIBODY; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; PENICILLIN G; PREDNISONE; SINGLE STRANDED DEOXYRIBONUCLEIC ACID ANTIBODY; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; JOINT CONTRACTURE; LINEAR SCLERODERMA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PUVA; SCHOOL CHILD; SKIN DISEASE;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; CONTRACTURE; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 57349117692     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080098     Document Type: Article

References (23)

1. Medsger TA Jr. Epidemiology of systemic sclerosis. Clin Dermatol 1994;12:207-16.
2. Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997;24:73-80.
3. Zulian F. Scleroderma in children. Pediatr Clin North Am 2005;52:521-45, vii.
4. Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol 2006;18:606-13.
5. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995;70:1068-76.
6. Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology Oxford 2006;45:614-20.
7. Marzano AV, Menni S, Parodi A, et al. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol 2003;13:171-6.
8. Falanga V, Medsger TA, Reichlin M. High titers of antibodies to single-stranded DNA in linear scleroderma. Arch Dermatol 1985;121:345-7.
9. Falanga V, Medsger TA Jr, Reichlin M, Rodnan GP. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 1986;104:849-57.
10. Hayakawa I, Hasegawa M, Takehara K, Sato S. Anti-DNA topoisomerase II alpha autoantibodies in localized scleroderma. Arthritis Rheum 2004;50:227-32.
11. Kikuchi K, Takehara K, Ishibashi Y. Antinuclear antibodies in localized scleroderma: unique staining in chromosome spreads. J Am Acad Dermatol 1989;21:1301-3.
12. Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Rheumatoid factor isotypes in localized scleroderma. Clin Exp Dermatol 2005;30:405-8.
13. Rosenberg AM, Uziel Y, Krafchik BR, et al. Antinuclear antibodies in children with localized scleroderma. J Rheumatol 1995;22:2337-43.
14. Ruffatti A, Peserico A, Rondinone R, et al. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus. Arch Dermatol 1991;127:1180-3.
15. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 1994;31:567-71.
16. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Antigen specificity of antihistone antibodies in localized scleroderma. Arch Dermatol 1994;130:1273-7.
17. Sato S, Ihn H, Soma Y, et al. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 1993;36:1137-41.
18. Sato S, Kodera M, Hasegawa M, Fujimoto M, Takehara K. Antinucleosome antibody is a major autoantibody in localized scleroderma. Br J Dermatol 2004;151:1182-8.
19. Ruffatti A, Peserico A, Glorioso S, et al. Anticentromere antibody in localized scleroderma. J Am Acad Dermatol 1986;15:637-42.
20. Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y. Antinuclear antibodies in localized scleroderma. Arthritis Rheum 1983;26:612-6.
21. Takehara K, Sato S. Localized scleroderma is an autoimmune disorder. Rheumatology Oxford 2005;44:274-9. Erratum in: Rheumatology Oxford 2005;44:569.
22. Arkachaisri T, Pino S. Localized scleroderma severity index and global assessments: a pilot study of outcome instruments. J Rheumatol 2008;35:650-7.
23. el-Azhary RA, Aponte CC, Nelson AM. Do antihistone autoantibodies reflect disease activity in linear scleroderma? Arch Dermatol 2004;140:759-60.